相似文献
1
Teaching trainees to negotiate research collaborations with industry: a mentorship model.
Am J Psychiatry. 2010 Apr;167(4):381-6. doi: 10.1176/appi.ajp.2009.08121886.
2
Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
CMAJ. 1995 Sep 1;153(5):553-9.
3
Interactions of staff and residents with pharmaceutical industry: a survey of psychiatric training program policies.
Ann R Coll Physicians Surg Can. 2002 Dec;35(8 Suppl.):541-6.
4
Psychiatric resident and faculty views on and interactions with the pharmaceutical industry.
Acad Psychiatry. 2010 Mar-Apr;34(2):102-8. doi: 10.1176/appi.ap.34.2.102.
5
Trainees and collaborations with industry.
Am J Psychiatry. 2010 Sep;167(9):1127; author reply 1127. doi: 10.1176/appi.ajp.2010.10040621.
6
Psychiatric training program engagement with the pharmaceutical industry: an educational issue, not strictly an ethical one.
Acad Psychiatry. 2005 May-Jun;29(2):215-21. doi: 10.1176/appi.ap.29.2.215.
7
Partnerships between academic psychiatry and the pharmaceutical industry.
Australas Psychiatry. 2005 Mar;13(1):83-4; author reply 84-6. doi: 10.1080/j.1440-1665.2005.02157_1.x.
8
Collaborations between academic psychiatry and the pharmaceutical industry: a perspective from industry.
Epidemiol Psichiatr Soc. 2007 Jul-Sep;16(3):197-8.
9
Key aspects of physician and pharmaceutical industry relationships for trainees.
Acad Psychiatry. 2010 Mar-Apr;34(2):98-101. doi: 10.1176/appi.ap.34.2.98.
10
A teaching drill in child psychiatry.
Am J Psychiatry. 1975 Feb;132(2):158-63. doi: 10.1176/ajp.132.2.158.
引用本文的文献
1
Conflicts of Interest in Medicine. A Systematic Review of Published and Scientifically evaluated Curricula.
GMS J Med Educ. 2017 Aug 15;34(3):Doc37. doi: 10.3205/zma001114. eCollection 2017.
本文引用的文献
1
Comparative utility of aripiprazole and haloperidol in schizophrenia: post hoc analysis of two 52-week, randomized, controlled trials.
Appl Health Econ Health Policy. 2009;7(2):109-19. doi: 10.1007/BF03256145.
2
Industry support of medical education.
JAMA. 2008 Sep 3;300(9):1071-3. doi: 10.1001/jama.300.9.1071.
3
Industry-sponsored clinical research: a broken system.
JAMA. 2008 Sep 3;300(9):1069-71. doi: 10.1001/jama.300.9.1069.
4
New developments in managing physician-industry relationships.
JAMA. 2008 Sep 3;300(9):1067-9. doi: 10.1001/jama.300.9.1067.
5
Impugning the integrity of medical science: the adverse effects of industry influence.
JAMA. 2008 Apr 16;299(15):1833-5. doi: 10.1001/jama.299.15.1833.
6
Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation.
JAMA. 2008 Apr 16;299(15):1813-7. doi: 10.1001/jama.299.15.1813.
7
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.
JAMA. 2008 Apr 16;299(15):1800-12. doi: 10.1001/jama.299.15.1800.
8
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.
Lancet. 2008 Mar 29;371(9618):1085-97. doi: 10.1016/S0140-6736(08)60486-9.
9
Selective publication of antidepressant trials and its influence on apparent efficacy.
N Engl J Med. 2008 Jan 17;358(3):252-60. doi: 10.1056/NEJMsa065779.
10
Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis.
J Clin Psychiatry. 2007 Dec;68(12):1901-6. doi: 10.4088/jcp.v68n1210.
Zotero 插件